LIQUIDIA CORPORATION Other Non-Current Assets
LIQUIDIA CORPORATION (LQDA) had Other Non-Current Assets of $19.30 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-12
- 2026-06-30: Other Assets, Noncurrent $19.30M.
- 2026-03-31: Other Assets, Noncurrent $16.90M.
- 2025-12-31: Other Assets, Noncurrent $13.17M.
- 2025-09-30: Other Assets, Noncurrent $8.95M.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $19.30M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $16.90M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $13.17M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $8.95M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $22.42M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $15.54M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $10.92M 10-K · filed 2026-03-05 |
| 2024-09-30 | $7.76M 10-Q · filed 2024-11-13 |
| 2023-12-31 | $287.00K 8-K · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |